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Although adrenal incidentalomas (AI) are not associatedwith
clinically evident syndromes, some patients display biochem-
ical features of subclinical hypercortisolism (SH). Previous
studies indicated a negative effect of SH on bone in AI pa-
tients, but the prevalence of vertebral fractures and the roles
of SH and gonadal status in volumetric bone mineral density
are unknown. In 70 female AI patients and 84 controls, the
prevalence of vertebral fractures and spinal bone mineral
density (by quantitative computed tomography) were evalu-
ated. Subjects were subdivided according to menopausal sta-
tus into groups Pre (21 patients and 23 controls) and Post (49
patients and 61 controls); there were 14 and 35 patients with-
out SH (SH) and 7 and 14 patients with SH (SH) in groups
Pre and Post, respectively. The prevalence of fractures was
higher in SH than in controls and in SH subjects in both
groupsPre [SH, 42.9%; controls, 0% (P 0.001); SH, 7.1% (P
0.049)] and post [SH, 78.6%; controls, 37.7% (P  0.006); SH
42.9% (P0.024)]. IngroupPost, themeanz-scorequantitative
computed tomography values were lower in SH patients
(0.78 0.29) than in controls (0.06 0.14; P 0.011) and SH
patients (0.02  0.19; P  0.034). Evaluation of spinal bone is
indicated in female AI patients with SH. (J Clin Endocrinol
Metab 89: 2237–2241, 2004)
INCIDENTALLY DISCOVERED ADRENAL masses [ad-renal incidentalomas (AI)] have been frequently detected
in recent years, because of the increasing use of abdominal
imaging techniques (1–4). Endocrinological work-up shows
that the great majority of these lesions are adrenocortical
adenomas, and some of these patients present a subtle degree
of cortisol hypersecretion (5–11), which is commonly defined
as subclinical hypercortisolism (SH). Several previous stud-
ies suggested that SH lead to several complications, includ-
ing bone loss (12–19).
However, several issues remain unresolved about bone
involvement in SH. First, the effect on bone mass of gonadal
status in SH patients, particularly, volumetric trabecular
bone mass, which is the one mainly affected by both SH and
hypogonadism, should be assessed. Second, the prevalence
of fractures, which is the outcome of SH and hypogonadism
on bone, should be evaluated.
We investigated the volumetric trabecular bone mineral
density (BMD) of lumbar spine (L1–L4) by single energy
quantitative computed tomography (QCT) as well as the
prevalence of vertebral fractures in a relatively large sample
of female AI patients, looking for the relative influence of
gonadal status and SH.
Subjects and Methods
Subjects
Only female subjectswere studied, to avoid gender-related confound-
ing effects on the skeleton (20). Ninety-three AI female patients, referred
to our center between September 1997 and November 2002, were ret-
rospectively evaluated. Twenty-three patients receiving treatments
known to affect bone or affected by diseases known to interfere with
skeletal or mineral metabolism were excluded from the study. Data
analysis was then performed on the remaining 70 patients. Eighty-four
healthy female subjects (23 premenopausal and 61 postmenopausal)
collected between January 2001 and December 2002 were selected as
controls.
Diagnosis of AI was based on the presence of an unilateral adrenal
mass by noninvasive abdominal imaging techniques, performed for
unrelated diseases, and the lack of overt signs and/or symptoms of
hormonal hypersecretion. No subject had evidence ofmetastatic disease.
At computed tomography, all lesions were homogeneous, hypodense,
and well shaped, features compatible with the diagnosis of adrenocor-
tical adenoma (4).
Diagnosis of SH was based on the presence of at least two out of the
following three alterations of the hypothalamic-pituitary-adrenal axis
(11): 1) urinary free cortisol (UFC) levels above 70.0 g/24 (193.1
nmol/24 h), the cut-off of both our own and international (21) normal
reference values; 2) serum cortisol levels after a 1-mg overnight dexa-
methasone suppression test above 3.0 g/dl (82.8 nmol/liter); and 3)
ACTH levels below 10 pg/ml (2.2 pmol/liter). No patient with SH
showed clinical features compatible with Cushing’s syndrome (i.e. striae
rubrae, moon face, buffalo hump, or hirsutism); moreover, no patients
reported acute back pain.
Abbreviations: BMD, Bone mineral density; CI, confidence interval;
OR, odds ratio; QCT, quantitative computed tomography; ROI, region
of interest; SH, subclinical hypercortisolism; UFC, urinary free cortisol.
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The whole sample was subdivided on the basis of gonadal status in
group Pre (21 premenopausal AI patients and 23 control subjects) and
group Post (49 postmenopausal AI patients and 61 control subjects). The
two groups of AI patients were further separated according to SH was
concerned: in group Pre, seven patients were affected by SH (SH),
whereas 14 were not (SH); in group Post, 14 patients were SH, and
35 were SH. The sample’s characteristics, such as age, years since
menopause, estradiol levels, height, weight, and body mass index, are
shown in Table 1. Estradiol levels were higher than 40 pg/ml (146.8
pmol/liter) in all premenopausal subjects andwere lower than 20 pg/ml
(73.4 pmol/liter) in all postmenopausal subjects, without any difference
among SH, SH, and control subjects.
The diameter of incidentalomas was not different between SH and
SH patients in both group Pre (SH: mean  se, 2.9  0.4 cm; range,
1.0–8.0; SH: mean  se, 2.9  0.6 cm; range, 0.9–5) and group Post
(SH: mean  se, 2.9  0.2; range, 1.0–5.5; SH: mean  se, 3.2  0.3;
range, 1.5–5.5 cm). Pheochromocytoma and aldosteronoma were ex-
cluded by appropriate hormonal measurements (24-h urinary cat-
echolamines and plasma renin activity and aldosterone in the recumbent
position and after 3 h of upright position).
The studywas approved by local ethical committee and in accordance
with Helsinki Declaration II.
Methods
In all AI patients, serum and urinary sampleswere collected at 0800 h.
Serum cortisol and UFC levels (after dichloromethanol extraction) were
determined immunofluorimetrically by TDX-FLX kits (Abbott Diagnos-
tika, Wiesbaden-Delkenheim, Germany); serum ACTH levels (mean of
three determinations at 20-min intervals) were measured by immuno-
radiometric assay (BRAHMS Diagnostica, Berlin, Germany).
In all subjects, spinal L1–L4 BMD was measured by single energy
QCT using a CT 600S scanner (ToshibaMedical SystemDivision, Tokyo,
Japan; in vivo precision, 1.8%) and a nonsimultaneous calibration system
(Lumbar Reference Simulator, CIRS, Norfolk, VA). The region of interest
(ROI) in the axial plane was carried out bymanually placing an elliptical
ROI in the trabecular part of the vertebral body. After performing the
scan, the average attenuation in the ROI was measured in the image,
compared with the attenuation values of the reference standard, and
finally expressed in mineral equivalents in milligrams per cubic centi-
TABLE 1. Clinical characteristics of patients
Group Pre Group Post
Controls (n  23) SH (n  14) SH (n  7) Controls (n  61) SH (n  35) SH (n  14)
Age (yr) 41.7  2.0 39.3  2.2 42.9  3.5 60.8  0.9 61.5  1.4 63.9  2.2
(21–54) (24–52) (26–50) (44–75) (48–80) (46–79)
YSM 14.6  1.0 13.6  1.2 14.9  2.0
(4–34) (4–32) (4–32)
Estradiol (pmol/liter) 225.2  13.6 226.5  21.0 237.1  32.1 23.1  2.4 26.4  3.7 19.3  4.4
(154.1–444.8) (157.8–411.0) (151.9–359.7) (0.0–72.7) (0.0–72.3) (0.0–51.0)
Weight (kg) 71.6  3.3 80.1  5.5 74.9  3.1 71.8  1.9 77.7  2.6 67.1  1.7a
(46–110) (43–121) (63–84) (43–107) (53–134) (59–79)
Height (m) 1.59  0.01 1.59  0.04 1.58  0.03 1.54  0.01 1.54  0.01 1.52  0.01
(1.48–1.68) (1.47–1.68) (1.51–1.68) (1.41–1.70) (1.39–1.66) (1.46–1.61)
BMI (kg/m2) 28.3  1.35 31.7  2.3 30.1  1.5 30.5  0.8 32.5  1.0 29.1  0.7
(18.0–45.2) (17.1–47.3) (23.1–36.0) (19.1–47.3) (24.5–50.4) (24.6–32.9)
Data are the mean SE (range). Group Pre, Premenopausal females; Group Post, postmenopausal females; SH, patients without SH; SH,
patients with SH; YSM, years since menopause.
a P  0.05 vs. Pre SH.
TABLE 2. Biochemical parameters of cortisol secretion, volumetric vertebral bone mineral density, and prevalence of patients with
vertebral fractures
Group Pre Group Post
Controls (n  23) SH (n  14) SH (n  7) Controls (n  61) SH (n  35) SH (n  14)
F-Dex (g/dl) 1.85  0.35 4.40  1.57a 1.96  0.16 6.6  1.40b
(0.70–5.70) (0.70–12.60) (0.70–4.50) (1.70–19.90)
ACTH (pg/ml) 12.72  1.81 6.36  0.90a 13.60  1.18 6.36  0.60b
(5.90–24.54) (0.90–10.00) (3.18–34.10) (3.18–10.0)
UFC (g/24 h) 50.02  3.70 74.84  10.51a 41.1  4.09 61.2  6.48c
(26.28–69.01) (44.40–113.05) (11.90–144.03) (23.99–104.02)
QCT (z-values)d 0.13  0.26 0.57  0.34 0.11  0.48 0.06  0.14 0.02  0.19 0.78  0.29e,f
(1.95–2.33) (1.64–2.57) (1.91–1.77) (1.96–2.20) (1.69–2.21) (2.49–1.24)
No. of patients with 0 1 3a,g 23 15 11e,h
fractures (%) [0.0] [7.1] [42.9] [37.7] [42.9] [78.6]
Data are the mean SE (range). The prevalence in the group is in brackets. Group Pre, Premenopausal females; Group Post, postmenopausal
females; SH, patients without SH; SH, patients with SH; UFC, normal values less than 70.0 g/24 (193.1 nmol/24 h); ACTH, mean of three
determinations at 0800 h, normal values above 10 pg/ml (2.2 pmol/liter); F-Dex, serum cortisol at 0800 h after 1 mg overnight dexamethasone,
normal values less than 3.0 g/dl (82.8 nmol/liter) (conversion factors: F-Dex, 27.59; ACTH, 0.22; UFC, 2.759); QCT, vertebral trabecular
volumetric L1–L4 BMD.
a P  0.05 vs. SH in group Eu.
b P  0.0001 vs. SH.
c P  0.01 vs. SH.
d Adjusted for weight and height.
e P  0.05 vs. SH.
f P  0.05 vs. controls in group Hypo.
g P  0.001 vs. controls.
h P  0.01 vs. controls in group Hypo.
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meter. Individual BMD values were expressed as sd units (z-values) in
relation to reference population of our center, which includes 382
healthy female subjects (22).
Conventional spinal radiograph in lateral (T4–L4) and antero-
posterior (L1–L4) projections were obtained in all subjects using a stan-
dardized technique. Two trained radiologists, who were blinded to the
individual’s status (patient or control subject), BMD, and hormonal
results, reviewed the radiographs independently. The two radiologists
discussed questionable cases to agree on a diagnosis. Vertebral fractures
were diagnosed on visual inspection using the semiquantitative method
previously described by Genant et al. (23, 24). According to this tech-
nique, fractures assessed on lateral thoracolumbar spine radiographs
were defined as reductions of more than approximately 20% in anterior,
middle, or posterior vertebral height and were graded by severity.
Statistical analysis
Descriptive statistics are expressed as the mean  se. For each vari-
able, after testing normality of distribution by Kolmogorov-Smirnov
test, univariate ANOVA was used to compare BMD data of controls,
SH, and SH patients in groups Pre and Post. Multivariate linear
regression analysis was then used to evaluate the influence on BMD of
the categorical variables SH and gonadal status. A 2 test was used to
compare the prevalence of vertebral fractures in controls, SH, and SH
patients in groups Pre andPost. Agreement between the two radiologists
was calculated using  statistics.
Finally, logistic regression analysis was performed to evaluate the
influence of either SH and gonadal status or BMD on the prevalence of
fractures. A value of P  0.05 was considered significant.
Results
Descriptive statistics of patients and controls are reported
in Table 1. Data regarding pituitary-adrenal axis function (i.e.
serum cortisol levels after a 1-mg overnight dexamethasone
suppression test, ACTH, and UFC) were consistent with the
diagnostic criteria of SH previously mentioned. In addition,
in group Post, but not in group Pre, bone mass, after ad-
justment for weight and height, was significantly lower in
SH than in controls and SH patients (Table 2). The same
results were observedwithout adjusting BMD for height and
weight or without considering subjects with BMI greater
than 40 kg/m2 (data not shown).
The multivariate linear regression analysis, after correc-
tion for weight and height, showed that although both SH
and gonadal status were independent significant predictors
of BMD, they did not interact with each other in influencing
bone mass (Table 3A).
In the whole sample, 30 patients (42.8%) and 23 controls
(27.3%) showed at least one vertebral fracture. The severity
degree was mild (grade 1) in 27 patients and in 22 controls,
and moderate (grade 2) in three patients and one control
subject. In both groups Pre and Post, the prevalence of pa-
tients with fracture was higher in SH than in controls and
SH patients (Table 2 and Fig. 1). Taking into account more
than one fracture in the same patient, in group Post we
observed five control subjects and seven patients with two
fractures (three SH and four SH). Interrater reliability
between two radiologists was good (k  0.87).
Logistic regression analysis showed that SH and gonadal
status were significant predictors of the prevalence of frac-
tures (Table 3B). However, gonadal status after adjusting for
age was not a significant predictor of fractures (P  0.073)
with this sample size (Table 3C). SH and gonadal status did
not interact each other in influencing fractures (Table 3, B and
C). Separately analyzing Groups Pre and Post, SH signifi-
cantly predicted fractures only in the latter group [group Pre:
odds ratio (OR), 12.66; 95% confidence interval (CI), 0.83–
192.70; P  0.068; group Post: OR, 4.69; 95% CI, 1.10–20.00;
P  0.037]. Finally, high BMD z-values significantly pre-
dicted a low prevalence of fracture in AI patients (OR, 0.50;
95% CI, 0.31–0.80; P  0.004).
Discussion
This is the first study evaluating the effect of subclinical
cortisol hypersecretion and gonadal status on spinal volu-
metric trabecular bone density and vertebral fractures in a
large sample of patients with AI. Our data clearly show that
subtle hypercortisolism is associated with a high prevalence
FIG. 1. F, P  0.001 vs. controls; *, P  0.05 vs. SH (in group Pre).
§, P  0.01 vs. controls; ˆ, P  0.05 vs. SH (in group Post). See Sub-
jects and Methods for explanation of groups.
TABLE 3. Predictive values of gonadal status and/or SH on volumetric trabecular spinal BMD, the prevalence of fractured patients, and
the prevalence of fractured patients after adjustment for age
Volumetric
trabecular spine
BMDa
Prevalence of fractured patients Prevalence of fractured patientsadjusted for age
F P Odds ratio (95% CI) P Odds ratio (95% CI) P
Gonadal status (pre- or 4.76 0.033 6.88 0.007 6.04 0.073
postmenopausal) (1.71–27.59) (0.84–43.29)
SH (presence or absence) 5.90 0.018 5.88 0.006 5.79 0.007
(1.67–20.72) (1.62–20.62)
Interaction between gonadal 0.06 0.811 0.50 0.642 0.51 0.640
status and SH (0.03–9.19) (0.03–9.26)
CI, Confidence interval.
a Weight and height were included as covariates.
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of fractures independent of gonadal status. In addition, tra-
becular volumetric bone mass at the lumbar spine was af-
fected by SH regardless of gonadal status, as indicated by
multivariate analysis, although BMD was mainly affected
among postmenopausal women.
Interestingly, the detrimental effect of subclinical cortisol
hypersecretion on the vertebrae accounts for the very high
prevalence of fractures we found in our AI patients, which
exceeds the corresponding figures in the control group. It is
also worth noting that the high number of vertebral fractures
was clinically unexpected, because no patient reported back
pain. The vast majority of the fractures were mild and were
not detectable without an accuratemorphological evaluation
of the radiographs.
Logistic regression analysis showed a significant influence
of gonadal status on fractures, even if it was lost when in-
cluding age in the model. This result is probably due to the
fact that age partially conceals the effect of menopause.
The higher prevalence of vertebral fractures in AI patients
in the presence of SH is only partially explained by the
reduced spinal BMD. We hypothesize that subtle cortisol
excess may exert an integrated detrimental effect on trabec-
ular bone quality, as previously suggested (19). The negative
influence of SH on connective tissue (25) andmuscle strength
could also contribute to the increased fracture risk. The del-
eterious effect of SH on the quality of trabecular bone and on
connective tissue may also explain the unexpected increased
prevalence of fractures we found in premenopausal AI
women with subclinical hypercortisolism; nevertheless, this
finding needs to be confirmed on a larger sample of pre-
menopausal AI patients with SH.
Our data on BMD are in line with previous results ob-
tained by our and other groups in relatively small samples
of AI patients, in which spinal areal (determined by dual
energy x-ray absorptiometry) and volumetric (by QCT) bone
density were cross-sectionally and longitudinally evaluated
(12, 15, 18). Our current findings are interesting, because
QCT directly measures the volumetric bone density of a
cubic slice of trabecular vertebral tissue, whereas DXA de-
vices only provide its indirect estimate (26, 27). Thus, as
trabecular bone tissue is noticeably affected by glucocorti-
coid excess (28), the QCT technique, although it appears to
be more apt to accurately identify the effect of SH, confirms
the results obtained with DXA in a small sample (12).
Collectively taken, our data confirm the need to study
trabecular bone mineral density at the spine at least in post-
menopausal patients with AI and suggest that thoraco-
lumbar spine radiographs should be obtained in AI patients
with subtle hypercortisolism. In these subjects, indeed, the
detection of glucocorticoid excess complications, such as the
reduction of bone mass and/or the presence of vertebral
fractures, becomes one of the pivotal criteria when deciding
whether these tumors deserve surgical excision.
In conclusion, female AI patients with SH display in-
creased fracture prevalence together with low BMD at the
lumbar spine; the latter is being particularly affected in post-
menopausal subjects. These findings should be taken into
account when addressing the treatment of choice in patients
with adrenal incidentalomas.
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